(137 days)
Not Found
No
The summary describes a standard electrosurgical device with manual controls for mode and power, and there is no mention of AI or ML in the device description, intended use, or performance studies.
No
The device is used to cut and coagulate tissue during surgical procedures, which are therapeutic interventions, but the device itself is a surgical tool and not a therapeutic device that directly treats a condition or disease.
No
The device is described as an electrosurgical device intended for cutting and coagulating tissue during surgical procedures, not for diagnosing conditions.
No
The device description explicitly states it is a "hand-held monopolar electrosurgical instrument" and details physical components like a handset, buttons, a slider control, a blade electrode, and a cord, indicating it is a hardware device.
Based on the provided information, the Force TriVerse Electrosurgical Device is not an IVD (In Vitro Diagnostic) device.
Here's why:
- Intended Use: The intended use clearly states the device is for use in surgical procedures to cut and/or coagulate tissue using electrosurgical energy. This is an in vivo application (within a living organism).
- Device Description: The description details a hand-held instrument used by a surgeon to directly interact with tissue during surgery.
- Lack of IVD Characteristics: There is no mention of the device being used to examine specimens (like blood, urine, or tissue samples) outside of the body to provide information for diagnosis, monitoring, or screening.
IVD devices are specifically designed to perform tests on samples taken from the human body to provide diagnostic information. The Force TriVerse Electrosurgical Device is a surgical tool used directly on the patient during a procedure.
N/A
Intended Use / Indications for Use
The Force TriVerse Electrosurgical Device is a single-use device intended for use in open surgical procedures (such as general, urologic, thoracic, plastic and reconstructive, gynecologic), and minimally invasive arthroscopic procedures where the surgeon desires monopolar radio-frequency electrosurgical energy to cut and/or coagulate tissue. The electrosurgical device is intended for use with conventional monopolar electrodes.
Product codes
GEI
Device Description
The Force TriVerse Electrosurgical Devices are radiation-sterilized, single-use, hand-held monopolar electrosurgical instruments. There are two models-FT3000DB. These models are identical except for the cord length. FT3000 has a 10-ft cord and FT3000DB has a 15-ft cord.
The instruments work with compatible electrosurgical generators to cut and coagulate tissue during surgical procedures. The surgeon uses the controls on the handset to select the electrosurgical mode and to adjust the power output from within the surgical field. The surgeon selects the desired electrosurgical mode by pressing one of three buttons. The surgeon controls the power level using a slider control on the instrument body. The device is assembled with a blade electrode. The surgeon is able to replace this electrode with other standard monopolar electrodes as needed for a specific surgical procedure.
The device is provided with a safety holster to provide a safe location for storing the instrument when it is not in use.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies
Evidence of safety and effectiveness was presented in the previously submitted 510(k), which also demonstrated the compatibility of these instruments with the ForceTriad™ Energy Platform. Additional testing has been completed to demonstrate that the device still performs as expected following the design changes. The testing included:
- Testing in accordance with applicable clauses of IEC 60601-1
- Testing in accordance with applicable clauses of IEC 60601-2-2
- . Testing in accordance with applicable clauses of IEC 60601-1-2
- Mechanical testing (such as mechanical strength, integrity of connections, performance of button and slider controls,resistance to fluids, and label adhesion)
- . Shipping tests to verify that the packaging adequately protects the device
- o Biocompatibility testing of direct and indirect patient-contacting materials (cytotoxicity, intracutaneous reactivity, sensitization, hemolysis, and acute systemic injection)
Key Metrics
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 878.4400 Electrosurgical cutting and coagulation device and accessories.
(a)
Identification. An electrosurgical cutting and coagulation device and accessories is a device intended to remove tissue and control bleeding by use of high-frequency electrical current.(b)
Classification. Class II.
0
Image /page/0/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo features a stylized image of an eagle or bird with three human profiles nested within its form. The text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" is arranged in a circular pattern around the image.
Food and Drug Administration 10903 New Hampshire Avenue Document Control Center - WO66-G609 Silver Spring, MD 20993-0002
Covidien Ms. Nancy Sauer Regulatory Affairs Product Manager 5920 Longbow Drive Boulder, Colorado 80301
August 4, 2015
Re: K150735
Trade/Device Name: Force Triverse Electrosurgical Device, Holster, 10-foot Force Triverse Electrosurgical Device, Holster, 15-foot Regulation Number: 21 CFR 878.4400 Regulation Name: Electrosurgical cutting and coagulation device and accessories Regulatory Class: Class II Product Code: GEI Dated: June 29, 2015 Received: July 1, 2015
Dear Ms. Sauer:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR [SELECT ONE: Part 801 [or, for IVDs only] Parts 801 and 809]); medical device reporting (reporting of medical device-related adverse events) (21 CFR
1
803); good manufacturing practice requirements as set forth in the quality systems (OS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Industry and Consumer Education at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Joshua C. Nipper -S
Binita S. Ashar, M.D., M.B.A., F.A.C.S.
Director For
Division of Surgical Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
2
Indications for Use
510(k) Number (if known) K150735
Device Name
Force Triverse Electrosurgical Device, Holster, 10-foot Force Triverse Electrosurgical Device, Holster, 15-foot
Indications for Use (Describe)
The Force TriVerse Electrosurgical Device is a single-use device intended for use in open surgical procedures (such as general, urologic, thoracic, plastic and reconstructive, gynecologic), and minimally invasive arthroscopic procedures where the surgeon desires monopolar radio-frequency electrosurgical energy to cut and/or coagulate tissue. The electrosurgical device is intended for use with conventional monopolar electrodes.
| Type of Use (Select one or both, as applicable) | |
|---|---|
| Prescription Use (Part 21 CFR 801 Subpart D) | Over-The-Counter Use (21 CFR 801 Subpart C) |
CONTINUE ON A SEPARATE PAGE IF NEEDED.
This section applies only to requirements of the Paperwork Reduction Act of 1995.
DO NOT SEND YOUR COMPLETED FORM TO THE PRA STAFF EMAIL ADDRESS BELOW.
The burden time for this collection of information is estimated to average 79 hours per response, including the time to review instructions, search existing data sources, gather and maintain the data needed and complete and review the collection of information. Send comments regarding this burden estimate or any other aspect of this information collection, including suggestions for reducing this burden, to:
Department of Health and Human Services Food and Drug Administration Office of Chief Information Officer Paperwork Reduction Act (PRA) Staff PRAStaff@fda.hhs.gov
"An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB number."
3
Image /page/3/Picture/0 description: The image contains the word "COVIDIEN" in a sans-serif font. To the left of the word is a blue square with a white rectangle in the center. The square is divided into four smaller squares, with the top left and bottom right squares being a darker shade of blue than the top right and bottom left squares.
510(k) Summary
Date summary prepared: 6/25/15
510(k) Submitter/Holder
Covidien 5920 Longbow Drive Boulder, CO 80301
Contact
Nancy Sauer Regulatory Affairs Product Manager Telephone: 303-581-6791 Fax: 303-530-6313 Email: nancy.sauer@covidien.com
Name of Device
| Trade Name: | Force TriVerse™ Electrosurgical Device |
|---|---|
| Catalog Numbers: | FT3000 and FT3000DB |
| Common Name: | Monopolar Electrosurgical Instrument |
| Classification Name: | Electrosurgical cutting and coagulation device and accessories (21 CFR 878.4400. Class II. GEI). |
Predicate Devices
These devices are legally marketed devices, manufactured by Covidien 11c. The Force Triverse devices were originally cleared for marketing under 510(k) K051627. These instruments serve as their own predicate devices.
Device Description
The Force TriVerse Electrosurgical Devices are radiation-sterilized, single-use, hand-held monopolar electrosurgical instruments. There are two models-FT3000DB. These models are identical except for the cord length. FT3000 has a 10-ft cord and FT3000DB has a 15-ft cord.
The instruments work with compatible electrosurgical generators to cut and coagulate tissue during surgical procedures. The surgeon uses the controls on the handset to select the electrosurgical mode and to adjust the power output from within the surgical field. The surgeon selects the desired electrosurgical mode by pressing one of three buttons. The surgeon controls the power level using a slider control on the instrument body. The device is assembled with a blade electrode. The surgeon is able to replace this electrode with other standard monopolar electrodes as needed for a specific surgical procedure.
The device is provided with a safety holster to provide a safe location for storing the instrument when it is not in use.
4
Indications for Use
This 510(k) is for changes to the indications for use of these devices. The primary change is to remove references to compatible devices and electrodes. The statement has also been revised for clarity and consistency. The new indications for use statement is:
The Force TriVerse Electrosurgical Device is a single-use device intended for use in onen surgical procedures (such as general, urologic, thoracic, plastic and reconstructive, gynecologic) and minimally invasive arthroscopic procedures where the surgeon desires monopolar radio-frequency electrosurgical energy to cut and/or coagulate tissue. The electrosurgical device is intended for use with conventional monopolar electrosurgical electrodes.
Technological Characteristics
The Force TriVerse™ Electrosurgical Devices work in conjunction with Covidien electrosurgical generators. They use monopolar radiofrequency energy to cut and coagulate tissue. The devices provide controls that allow the surgeon to select one of three electrosurgical modes (cut, coagulate, or hemostasis with division, also known as Valleylab mode) and to control the power output from within the surgical field. The instrument connects to the generator by a 10-foot or 15-foot long cord, which has a proprietary connector. The Covidien generator recognizes the instrument through the connector and activates a unique user interface screen. The surgical team uses the combination of the generator user interface screen and the controls on the instrument to achieve the intended surgical effect (electrosurgical mode and power).
The instruments are rated for a maximum peak voltage of 3625 volts and when used with the specified generators, they meet the IEC 60601-1 criteria for Type CF applied parts.
The overall functionality and performance characteristics of the device are unchanged relative to the initially cleared device. However, some changes have been made in in materials used in the internal circuitry and the cable to improve manufacturability. Also, the safety holster packaged with the instrument has been made wider to more easily accommodate the cable during packaging.
Performance
Evidence of safety and effectiveness was presented in the previously submitted 510(k), which also demonstrated the compatibility of these instruments with the ForceTriad™ Energy Platform. Additional testing has been completed to demonstrate that the device still performs as expected following the design changes. The testing included:
- Testing in accordance with applicable clauses of IEC 60601-1
- Testing in accordance with applicable clauses of IEC 60601-2-2
- . Testing in accordance with applicable clauses of IEC 60601-1-2
- Mechanical testing (such as mechanical strength, integrity of connections, performance of button and slider controls,resistance to fluids, and label adhesion)
- . Shipping tests to verify that the packaging adequately protects the device
- o Biocompatibility testing of direct and indirect patient-contacting materials (cytotoxicity, intracutaneous reactivity, sensitization, hemolysis, and acute systemic injection)
Conclusion
The current version of the device and its labeling remains substantially equivalent to the original design and labeling.